GOSS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GOSS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Equity Investments only applies to insurance companies.
Richard Aranda | officer: Chief Medical Officer | 3013 SCIENCE PARK ROAD, SAN DIEGO CA 92121 |
Faheem Hasnain | director, officer: Executive Chairman | 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
Bryan Giraudo | officer: Chief Financial Officer | 7707 GATEWAY BOULEVARD, SUITE 140, NEWARK CA 94560 |
Waage Christian | officer: EVP & General Counsel | RECEPTOS, INC., 10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121 |
Caryn Peterson | officer: EVP, Regulatory Affairs | 3013 SCIENCE PARK ROAD, SAN DIEGO CA 92121 |
Sandra Milligan | director | 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
Laura Carter | officer: Chief Scientific Officer | 3013 SCIENCE PARK ROAD, SAN DIEGO CA 92121 |
Luisa Salter-cid | officer: Chief Scientific Officer | C/O GOSSAMER BIO, INC., 3013 SCIENCE PARK ROAD, SUITE 200, SAN DIEGO CA 92121 |
Jakob Dupont | officer: Chief Medical Officer | C/O ONCOMED PHARMACEUTICALS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063 |
Sheila Gujrathi | director, officer: President & CEO | 10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121 |
Omega Fund V Gp, L.p. | 10 percent owner | 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199 |
Omega Fund V Gp Manager, Ltd. | 10 percent owner | 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199 |
Omega Fund V, L.p. | 10 percent owner | 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199 |
Otello Stampacchia | director, 10 percent owner | 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199 |
Russell J. Cox | director | C/O JAZZ PHARMACEUTICALS, PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.